Cargando…
Effectiveness of COVID-19 vaccines on hospitalization and death in Guilan, Iran: a test-negative case-control study
OBJECTIVES: The present study was conducted to estimate the effectiveness of (BBIBP)-CorV (Sinopharm), ChAdOx1-S/nCoV-19 (AZD1222, Oxford-AstraZeneca), rAd26-rAd5 (Gam-COVID-Vac, Sputnik V), and BIV1-CovIran (COVIran Barekat) and BBV152 COVAXIN (Bharat Biotech) vaccines against hospitalization and d...
Autores principales: | Heidarzadeh, Abtin, Amini Moridani, Mohammadreza, Khoshmanesh, Saman, Kazemi, Samira, Hajiaghabozorgi, Marziyeh, Karami, Manoochehr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788848/ https://www.ncbi.nlm.nih.gov/pubmed/36572376 http://dx.doi.org/10.1016/j.ijid.2022.12.024 |
Ejemplares similares
-
Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020
por: Shakiba, Maryam, et al.
Publicado: (2021) -
Study protocol: cohort event monitoring for safety signal detection after vaccination with COVID-19 vaccines in Iran
por: Aliyari, Roqayeh, et al.
Publicado: (2022) -
Epidemiological status of dermatophytosis in Guilan, north of Iran
por: Fallahi, AA, et al.
Publicado: (2017) -
Prevalence of Tinnitus and Its Associated Factors in the PERSIAN Guilan Cohort Study
por: Panahi, Rasool, et al.
Publicado: (2023) -
Seroprevalence of Brucellosis among high risk individuals in Guilan, Iran
por: Nikokar, Iraj, et al.
Publicado: (2011)